Lenalidomide After Allo Transplant

NCT01750762 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Lymphoma

Interventions

DRUG: Lenalidomide

Sponsor

Beth Israel Deaconess Medical Center